- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02169986
Atopic Dermatitis Adherence Study
Family Practice Resident Research Project: Do Electronic Reminders Increase Adherence of Moisturizer Utilization in Paediatric Atopic Dermatitis?
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Non Adherence to treatment is a common concern among physicians because it is associated with negative impact on patients' health. Among the different factors that can explain why treatment adherence is so low, forgetfulness is the most common.
Several interventions have been put into practice. Some of them have been proven to be successful, others not. An effective intervention not only has to be successful but also practical.
Technology is an integral part of our everyday lives. In Canada, most adults have access to smartphones, which opens the door to a world of new innovations. Among these are useful applications designed to improve different aspects of every day life.
Electronic reminders are applications designed to send messages, which could improve the adherence to treatment. So far, there are several studies that have proven this benefit in older children and adult population. At this moment, there are no studies involving younger children. Therefore, in this study, the null hypothesis is that electronic reminders will improve the adherence to twice daily application of moisturizers among parents/caregivers of children 10 and under with atopic dermatitis.
The study population will be parents/caregivers of children age 10 and under with atopic dermatitis recruited from Dr. Bergman's paediatric dermatology clinic.
The parents/caregivers of the patients will be invited to participate in this project by the Medical Office Assistant who will send them a letter with the invitation one week before their scheduled appointment. If they agree to participate, they will be asked to sign a consent form and then they will be asked to select an unmarked envelope from a container. The envelopes contain the information for two different groups, one is the experimental and the other the control group.
The experimental group will have the extra task of downloading and utilizing an application called MediSafe. This application will be set up to send reminders two times per day. The control group will be encouraged to continue with the standard of care with no added intervention. Both groups will received a free unlabeled bottle of CeraVe cream. The moisturizer will be unlabeled so as not to allow parents/caregivers perceptions on a specific brand to affect their utilization. External forces such as advertising the parents/caregivers sees or cost of the product could affect the parents/caregivers perception of value and in turn affect adherence.
The parents/caregivers will also receive a calendar in which they have to mark every time their children have moisturizer applied. The calendar will be provided as label on the bottle of moisturizer.
If during the study period the parents/caregivers run out of moisturizer, they can return to the clinic to pick up extra bottles of moisturizer at no cost.
The atopic dermatitis of patients from both groups will be assessed using the EASI score at the beginning and at the end of the 28 days.
Additionally, the parents/caregivers of both groups will be asked to fill up a brief survey form. They will submit this form, along with the calendar label, in an unmarked envelope to maintain anonymity.
The bottles of moisturizer will be weighed before and after the study and also every time a refill of moisturizer is required, to determine the amount of moisturizer used by each group.
This study will follow the standard of care for treatment of atopic dermatitis; no treatment will be withheld.
The principal outcome of this study is to probe whether or not electronic reminders can improve the adherence of moisturizer use in parents/caregivers of children 10 years and under with atopic dermatitis. The changes in the EASI score of the patients after the study and the differences in the amount of moisturizer used per body surface area will be secondary outcomes.
The number of times the calendar label will be marked will reflect the adherence to the treatment. Other data such as severity of eczema, and amount of moisturizer used will be collected. The height, weight, severity of eczema and use of steroid/calcineurin inhibitors will provide additional information that could be used indirectly to measure adherence.
Regarding the data analysis:
Mean differences between the experimental and control groups on adherence and EASI scores will be analyzed using Student's t-test for independent groups. Possible difference on treatment compliance between baseline and post-implementation within the groups will be explored using Student's dependent t-test for paired samples. This pilot study's sample size will be sufficient for the planned analyses, and to help determine effect size and power needed to conduct a larger study on this topic. Univariate descriptive statistics will be reported for all variables.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: James H Bergman, MD
- Telefonnummer: 604-876-4433
- E-mail: bergmanjn@gmail.com
Studiesteder
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 1K1
- Dr Bergman's Paediatric Dermatologic Clinic
-
Ledende efterforsker:
- James H Bergman, MD RCPSC
-
Underforsker:
- Benedict Yap, MD
-
Underforsker:
- Pedro P Jara Villarroel, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Parents/caregivers of children age 10 and under with atopic dermatitis from Dr. Bergman's dermatology clinic.
- The parents/caregivers must have a smartphone and not already be using an electronic reminder system.
- At least one of the parents/caregivers must have an adequate level of English proficiency in order to follow the instructions required by this project mostly because the electronic reminders are available in English only.
Exclusion Criteria:
- All parents/caregivers of children over the age of 10 with atopic dermatitis.
- Patients receiving systemic immunosuppressive therapy.
- Patients who have a documented sensitivity to CeraVe.
- Parents/caregivers unable to follow instructions in English,
- Parents/caregivers without smartphones.
- Parents/caregivers already using electronic reminders.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Ingen indgriben: control group
Parents/caregivers will receive the standard of care.
|
|
Eksperimentel: electronic reminders
In this group, the parents/caregivers will receive two daily electronic reminders in addition to the standard of care.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Adherence
Tidsramme: Effects of electronic reminders on the adherence of 20 parents/caregivers at the end of 28 days study
|
The results on adherence of the 20 parents/caregivers in the experimental arm(using electronic reminders) will be contrasted with another 20 parents/caregivers in the control arm.
|
Effects of electronic reminders on the adherence of 20 parents/caregivers at the end of 28 days study
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
EASI score changes
Tidsramme: The EASI score of the patients' eczema will be measured at the beginning and end of the 28 days study
|
The differences in the EASI score on both groups can be used as and indirect measurement of the adherence of the parents/caregivers to the treatment.
|
The EASI score of the patients' eczema will be measured at the beginning and end of the 28 days study
|
Moisturizer
Tidsramme: The use of moisturizer among both groups could be used as an indirect measure of adherence to treatment
|
The moisturizer jar will be weighted at the beginning and end of the study.
That way the amount of moisturizer will be calculated in grams.
Because the body surface of the patients in both groups will be obtained at the beginning of the study, the amount of moisturizer per surface can be estimated.
If there are significant differences in the use of moisturizer among both groups per unit of surface, this could be used as an indirect measurement of adherence.
|
The use of moisturizer among both groups could be used as an indirect measure of adherence to treatment
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: James H Bergman, MD, University of British Columbia
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- H13-02932
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Atopisk dermatitis/eksem
-
Steven BakerAfsluttetKontakt Dermatitis of HandForenede Stater
-
University of Split, School of MedicineRekrutteringKontakt Dermatitis | Kontakt Dermatitis LokalirriterendeKroatien
-
Linda FuAvadim Technologies, Inc.Afsluttet
-
Genesis Health SystemUkendtDermatitis, kontaktForenede Stater
-
BayerAfsluttet
-
University of the PhilippinesCalmoseptine, Inc.AfsluttetBle DermatitisFilippinerne
-
University of Nove de JulhoAdriana da Silva MagalhaesTrukket tilbageInkontinensassocieret dermatitis | Bleudslæt | FotobiomodulationsterapiBrasilien
-
HealthPartners InstituteAfsluttetIrriterende kontaktdermatitisForenede Stater
-
University Ghent3MRekrutteringHudsår | Irriterende dermatitis | Stomisted DermatitisBelgien
Kliniske forsøg med electronic reminders
-
Elisabeth-TweeSteden ZiekenhuisErasmus Medical Center; Medical Center Haaglanden; ZonMw: The Netherlands... og andre samarbejdspartnereUkendtKognitiv svækkelse | Hjernetumor, primærHolland
-
CAMC Health SystemWVCTSIAfsluttet
-
YuanYuan MaRekruttering
-
Seattle Children's HospitalTickit Health SolutionsAfsluttetRisikoreduktionsadfærdForenede Stater
-
University of PittsburghTrukket tilbageMedicinadhærens | Bivirkninger på lægemiddel | Medicinsk manglende overholdelseForenede Stater
-
The University of Texas Health Science Center,...National Cancer Institute (NCI); Fox Chase Cancer Center; University of Kansas og andre samarbejdspartnereIkke rekrutterer endnuHoved- og halskræftForenede Stater
-
Johns Hopkins UniversityOnce Upon a Time FoundationAfsluttetDepressiv lidelse | Angstlidelser | Bipolar affektiv lidelseForenede Stater
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); American Lung Association og andre samarbejdspartnereAktiv, ikke rekrutterendeUnge voksne | Ukontrolleret astmaForenede Stater
-
China Medical University HospitalAfsluttet
-
University of California, San FranciscoUniversity of California, Berkeley; Tilburg UniversityAktiv, ikke rekrutterendeGliom af lav kvalitetForenede Stater